IRIS
SOLDANO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.151
AS - Asia 1.059
NA - Nord America 488
SA - Sud America 92
AF - Africa 13
OC - Oceania 1
Totale 8.804
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.978
US - Stati Uniti d'America 472
SG - Singapore 454
CN - Cina 282
VN - Vietnam 186
BR - Brasile 69
FR - Francia 60
HK - Hong Kong 57
IN - India 19
DE - Germania 18
FI - Finlandia 18
PT - Portogallo 17
GB - Regno Unito 15
ID - Indonesia 14
AR - Argentina 11
JP - Giappone 9
CA - Canada 8
ES - Italia 7
MX - Messico 7
PH - Filippine 7
BD - Bangladesh 6
ZA - Sudafrica 6
AT - Austria 5
EC - Ecuador 5
IQ - Iraq 5
SE - Svezia 4
KR - Corea 3
NL - Olanda 3
SA - Arabia Saudita 3
UA - Ucraina 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
IE - Irlanda 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
PL - Polonia 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TR - Turchia 2
TW - Taiwan 2
AU - Australia 1
CO - Colombia 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
RE - Reunion 1
RO - Romania 1
RU - Federazione Russa 1
SI - Slovenia 1
TG - Togo 1
TN - Tunisia 1
Totale 8.804
Salva come PNG Salva come JPEG
Città #
Genova 3.660
Genoa 2.352
Vado Ligure 473
Rapallo 453
Singapore 233
San Jose 114
Ashburn 62
Hong Kong 56
Lauterbourg 54
Council Bluffs 51
Ho Chi Minh City 51
Hanoi 44
St Louis 41
Beijing 39
New York 29
Helsinki 14
Bordighera 12
Los Angeles 12
Santa Clara 12
Frankfurt am Main 11
Haiphong 11
Biên Hòa 10
Porto 10
Da Nang 7
City of London 6
Matosinhos Municipality 6
Tokyo 6
Vienna 5
Chicago 4
Guangzhou 4
Hải Dương 4
Lappeenranta 4
Montreal 4
Ninh Bình 4
Orem 4
Thái Nguyên 4
Tianjin 4
Chennai 3
Gwynn Oak 3
Jakarta 3
Johannesburg 3
Manchester 3
Mexico City 3
Milan 3
Nagīna 3
Nha Trang 3
Nuremberg 3
Paris 3
Phoenix 3
Quito 3
São Paulo 3
Amsterdam 2
Atlanta 2
Baghdad 2
Brasília 2
Campinas 2
Can Tho 2
Catania 2
Copenhagen 2
Denver 2
Dhaka 2
Dublin 2
Lentate sul Seveso 2
London 2
Madrid 2
Marseille 2
Minsk 2
Mumbai 2
New Delhi 2
Ponta Grossa 2
Porto Alegre 2
Quezon City 2
Rio de Janeiro 2
Rochester 2
Rome 2
São Gonçalo 2
Taipei 2
The Dalles 2
Toronto 2
Turin 2
Uberlândia 2
Vinh 2
Warsaw 2
Yancheng 2
Zhuozhou 2
Zurich 2
Acará 1
Adana 1
Ajuricaba 1
Alagoinhas 1
Ambato 1
Amman 1
Anyang 1
As Samawah 1
Ashland 1
Augusta 1
Baguio City 1
Baltimore 1
Barbacena 1
Basingstoke 1
Totale 7.996
Salva come PNG Salva come JPEG
Nome #
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. 256
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 228
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 227
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 213
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 201
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 194
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 193
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 189
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 189
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 189
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 187
Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition 176
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. 175
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? 174
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 168
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 167
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 163
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 155
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 154
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients. 150
Role of MT1-MMP in the osteogenic differentiation. 147
Circadian rhythms: glucocorticoids and arthritis. 146
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases 143
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 142
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 141
Monocyte and macrophage phenotypes: a look beyond systemic sclerosis 140
Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. 138
NF-KB involvement for CTLA4-IG intracellular signaling in human macrophages 138
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 138
Pathophysiology of systemic sclerosis: current understanding and new insights. 137
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 133
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis 132
Estrogen receptors on macrophages in rheumatoid arthritis: target for rheumatic diseases or inflammation-related mechanism? a comparison with peritoneal macrophages from endometriosis 130
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 128
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. 122
Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis 119
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 118
Estrogens modulate the effects of leflunomide on cytokine production by cultures of human monocytic/macrophage cells. 116
Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study. 115
Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis. 115
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic 112
Use of glucocorticoids and risk of infections. 110
RELATIONSHIPS BETWEEN BONE LOSS AND DICKKOPF-1 (DKK-1) SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS 108
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 106
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 105
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 101
The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases 100
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 99
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 96
Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment. 95
Microvascular damage progression and scoring by capillaroscopy in systemic sclerosis 88
Calcitriol (1,25-Dihydroxy Vitamin D) modulates the aromatase expression and citokina production by cultured human monocytes/macrophages 87
POS0394 AMINAPHTONE SHORT-TERM TREATMENT REDUCES TGF-BETA PLASMA LEVELS IN SYSTEMIC SCLEROSIS PATIENTS WITH SECONDARY RAYNAUD’S PHENOMENON 85
Sex hormones and leflunomide treatment of human macrophage cultures: effects on apoptosis. 83
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study 80
Fibrosis in sclerodermia: endothelin increases fibronectin production and proliferation of skin Fibroblasts. 75
Identification and quantification of selected inflammatory genes modulated by leflunomide and prednisone treatment in early rheumatoid arthritis patients. 75
AB0080 IMBALANCE OF MONOCYTE/MACROPHAGE POLARIZATION IN PERIPHERAL BLOOD AND SYNOVIAL FLUID OF RHEUMATOID ARTHRITIS PATIENTS 75
AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY 74
AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY 64
AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS 63
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 62
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. 60
Influence of Seasonal Vitamin D Changes on Clinical Manifestations of Rheumatoid Arthritis and Systemic Sclerosis 60
null 58
SAT0300 SERUM FROM “EARLY” SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES 56
SAT0301 CIRCULATING FIBROCYTES FROM SYSTEMIC SCLEROSIS PATIENTS AS POSSIBLE TARGET OF CTLA4-IG TREATMENT: AN IN VITRO STUDY 49
SAT0293 EXOSOMES DERIVED FROM PLASMA OF SYSTEMIC SCLEROSIS (SSC) PATIENTS AND FROM SSC CULTURED FIBROBLASTS CONTAIN PRO-FIBROTIC MIRNA SIGNATURES AND COULD INDUCE MYOFIBROBLAST DIFFERENTIATION IN VITRO 48
Endogenous and exogenous environmental hormone D (vitamin D) suppliers in autoimmune rheumatic diseases 43
Understanding the immune-endocrine effects of vitamin D in SARS- CoV-2 infection: a role in protecting against neurodamage? 41
POS0330 NINTEDANIB (TYROSINE KINASE INHIBITOR) DOWNREGULATES THE TRANSITION OF CULTURED SYSTEMIC SCLEROSIS FIBROCYTES INTO MYOFIBROBLASTS AND THEIR PRO-FIBROTIC ACTIVITY 38
AB0185 Endothelin-1 stimulates the profibrotic alternative activated phenotype in cultured human macrophages isolated from systemic sclerosis patients 37
AB0182 In vitro characterization of dermal fibroblasts from systemic sclerosis patients 26
AB0682 CIRCULATING FIBROCYTES IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS PATIENTS: CORRELATION WITH DERMAL THICKNESS 24
AB0183 Isolation and characterization of circulating fibrocytes from systemic sclerosis patients: an vitro investigation 21
FRI0423 Effects of selexipag in cultured scleroderma skin fibroblasts 17
AB0185 Altered expression of relaxin receptor rxfp1/lgr7 in dermal fibroblasts contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis 17
THU0327 ANTIBODIES AGAINST EXTRACTABLE NUCLEAR ANTIGENS (ENA) IN SCLERODERMA ARE NOT ONLY DIAGNOSTIC AND PROGNOSTIC TOOLS, BUT PATHOGENETIC REGULATORS INDUCING A PROFIBROTIC PHENOTYPE IN CULTURED SKIN FIBROBLASTS 16
FRI0418 In vitro effects of ctla4-ig treatment on cultured fibrocytes from systemic sclerosis patients 16
FRI0417 Cd86 expression on cultured skin fibroblasts from systemic sclerosis patients: in vitro effects of ctla4-ig 12
Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study 11
THU0053 APREMILAST INHIBITS THE TGFî'1 MEDIATED TRANSITION OF CULTURED HUMAN SKIN FIBROBLASTS INTO PROFIBROTIC MYOFIBROBLASTS: IN VITRO STUDY 9
OP0212 Endothelin-1 induces a profibrotic phenotype in cultured human microvascular endothelial and circulating monocyte/macrophage cells 7
THU0348 IDENTIFICATION OF CIRCULATING CELLS WITH AN HYBRID M1/M2 MACROPHAGE PHENOTYPE IN SYSTEMIC SCLEROSIS PATIENTS AND CORRELATIONS WITH SELECTED CLINICAL ASPECTS 7
THU0347 TESTING THE IN VITRO EFFECTS OF NINTEDANIB ON CIRCULATING FIBROCYTES AND RESIDENT SKIN FIBROBLASTS FROM THE SAME SYSTEMIC SCLEROSIS PATIENTS: PRELIMINARY RESULTS 6
OP0296 Comparison of Bosentan and Macitentan Effects on Endothelial-To-Mesenchymal Transition Process Induced by ET-1 in Cultured Human Microvascular Endothelial Cells 6
SAT0252 AN EVALUATION OF THREE DIFFERENT METHODS TO EVALUATE SKIN IMPAIRMENT IN SYSTEMIC SCLEROSIS PATIENTS 6
FRI0033 TNFalpha Production In Cultured Human Macrophages after CTLA4-IG (abatacept) In Vitro Treatment 6
OP0082 Fibrosis and microangiopathy are the main histopathological hallmarks of scleroderma-related myopathy 5
FRI0404 Characterisation of a monocytes/macrophages cell subset co-expressing both m1 and m2 phenotype markers in systemic sclerosis patients 5
THU0525 Counting Synovial Fluid Monosodium Urate Crystals May Be Useful in The Management of Patients with Gout 4
THU0116 European multicentre pilot survey to assess vitamin d and clinical status in rheumatoid arthritis patients 4
THU0451 A method for counting calcium pyrophosphate crystals in the synovial fluid 4
SAT0323 The endothelial-to-mesenchymal transition (ENDOMT) in scleroderma can be prevented by the use of dual endothelin receptor antagonists bosentan and macitentan 2
Totale 9.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.529
article - articoli 25.631
book - libri 0
conference - conferenze 591
curatela - curatele 0
other - altro 307
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 42 51 41
2021/2022678 35 41 59 59 19 35 67 154 40 59 34 76
2022/2023548 49 39 13 38 83 78 7 39 87 10 94 11
2023/2024434 12 42 4 50 25 82 32 45 13 11 39 79
2024/20251.332 58 81 48 79 143 139 121 236 46 127 133 121
2025/20262.925 324 202 235 443 356 242 408 148 292 275 0 0
Totale 9.050